Brief: Alkem Laboratories Says Us FDA Inspection At Co's API Manufacturing Facility, Mandva Closed
Feb 28 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* CLOSURE OF US FDA INSPECTION AT COMPANY'S API MANUFACTURING FACILITY
LOCATED AT
MANDVA
* US FDA HAS ISSUED AN ESTABLISHMENT INSPECTION REPORT (EIR)
* INSPECTION HAS BEEN CLASSIFIED AS VOLUNTARY ACTION INDICATED AND WAS
CLOSED
ACCORDINGLY
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees